A02183 (2R,3R,4S,5S,6R)-2-(((2aR,3R,4S,5aS,5bS,7S,7aR,9S,11aR,12aS)-4-羟基-3-((2R,5S)-5-(2-羟基丙-2-基)-2-甲基四氢呋喃-2-基)-2a,5a,8,8-四甲基-9-(((2S,3R,4S,5R)-3,4,5-三羟基四氢-2H-吡喃-2-基)氧基)十四氢-1H,12H-环戊二烯并[a]环丙并[e]菲-7-基)氧基)-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇

(2R,3R,4S,5S,6R)-2-(((2aR,3R,4S,5aS,5bS,7S,7aR,9S,11aR,12aS)-4-Hydroxy-3-((2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-2a,5a,8,8-tetramethyl-9-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetradecahydro-1H,12H-cyclopenta[a]cyclopropa[e]phenanthren-7-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

别名：黄芪甲苷;黄芪皂苷IV;黄芪皂苷XIV;黄芪甙;黄芪甲苷IV;WAKO015-20691Ⅳ黄芪甲苷;黄芪多糖;黄芪甲甙;黄芪甲苷 USP标准品;黄芪甲苷(标准品);黄芪甲苷IV(P);黄芪甲苷标准品;黄芪甲苷对照品;黄芪提取物黄;黄芪皂苷Ⅲ;黄芪总皂苷;灵芝多糖;硝苯地平;猪苓多糖;黄芪皂苷Ⅳ;黄芪甲苷 IV 标准品;黄芪提取物;黄芪皂甙;黄芪甲苷; 黄芪皂苷IV;黄芪皂苷 IV;黄芪甲苷 IV;黄芪甲苷（标定对照品）黄芪甲苷;黄芪皂苷IV;黄芪皂苷XIV;黄芪甙;黄芪甲苷IV;WAKO015-20691Ⅳ黄芪甲苷;黄芪多糖;黄芪甲甙;黄芪甲苷 USP标准品;黄芪甲苷(标准品);黄芪甲苷IV(P);黄芪甲苷标准品;黄芪甲苷对照品;黄芪提取物黄;黄芪皂苷Ⅲ;黄芪总皂苷;灵芝多糖;硝苯地平;猪苓多糖;黄芪皂苷Ⅳ;黄芪甲苷 IV 标准品;黄芪提取物;黄芪皂甙;黄芪甲苷; 黄芪皂苷IV;黄芪皂苷 IV;黄芪甲苷 IV;黄芪甲苷（标定对照品）展开

CAS No. : 84687-43-4

分子式： C₄₁H₆₈O₁₄

分子量： 784.970234870911

大包装询价? 收藏产品

自营

货号	规格	目录价
A02183-100mg	100mg	¥28.00
A02183-250mg	250mg	¥58.00
A02183-1g	1g	¥178.00

中文名称	(2R,3R,4S,5S,6R)-2-(((2aR,3R,4S,5aS,5bS,7S,7aR,9S,11aR,12aS)-4-羟基-3-((2R,5S)-5-(2-羟基丙-2-基)-2-甲基四氢呋喃-2-基)-2a,5a,8,8-四甲基-9-(((2S,3R,4S,5R)-3,4,5-三羟基四氢-2H-吡喃-2-基)氧基)十四氢-1H,12H-环戊二烯并[a]环丙并[e]菲-7-基)氧基)-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇
中文别名	黄芪甲苷;黄芪皂苷IV;黄芪皂苷XIV;黄芪甙;黄芪甲苷IV;WAKO015-20691Ⅳ黄芪甲苷;黄芪多糖;黄芪甲甙;黄芪甲苷 USP标准品;黄芪甲苷(标准品);黄芪甲苷IV(P);黄芪甲苷标准品;黄芪甲苷对照品;黄芪提取物黄;黄芪皂苷Ⅲ;黄芪总皂苷;灵芝多糖;硝苯地平;猪苓多糖;黄芪皂苷Ⅳ;黄芪甲苷 IV 标准品;黄芪提取物;黄芪皂甙;黄芪甲苷; 黄芪皂苷IV;黄芪皂苷 IV;黄芪甲苷 IV;黄芪甲苷（标定对照品）
英文名称	(2R,3R,4S,5S,6R)-2-(((2aR,3R,4S,5aS,5bS,7S,7aR,9S,11aR,12aS)-4-Hydroxy-3-((2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-2a,5a,8,8-tetramethyl-9-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetradecahydro-1H,12H-cyclopenta[a]cyclopropa[e]phenanthren-7-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
英文别名	ASTRAGALOSIDE;9,19-CYCLOLANOSTANE-BETA-D-GLUCOPYRANOSIDE;ASTRAGALOSIDE IV;Astrasieversianin XIV;β-D-Glucopyranoside, (3β,6α,16β,20R,24S)-;Astragaloside Ⅳ;ASTRAGALOSIDE IV(P);ASTRAGALOSIDE IV(RG);beta-D-Glucopyranoside, (3beta,6alpha,16beta,20R,24S)-20,24-epoxy-16,25-dihydroxy-3-(beta-D-xylopyranosyloxy)-9,19-cyclolanostan-6-yl;Astragalus P.E;Astragalus extract;Astragalus Polysaccharides;CH83947;CH90651;cyclosieversioside F;cyclosiversioside F;KT Astragaloside IV;1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene,b-D-glucopyranoside deriv.;9,19-Cyclolanostane, b-D-glucopyranoside deriv.;Astraversianin XIV;Astragalus Root Extract;AstragalosideIV;(2R,3R,4S,5S,6R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R)-14-Hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl;(2R,3R,4S,5S,6R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R)-14-Hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol;Astragaloside IV;(3β,6α,16β,20R,24S)-20,24-Epoxy-16,25-dihydroxy-3-(β-D-xylopyranosyloxy)-9,19-cyclolanostan-6-yl β-D-glucopyranoside (ACI);1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene, β-D-glucopyranoside deriv. (ZCI);9,19-Cyclolanostane, β-D-glucopyranoside deriv. (ZCI);Cyclosieversioside F;Cyclosiversioside F;Astragaloside Iv,(S);84687-43-4;FT-0686574;83207-58-3;NS00018369;(2R,3R,4S,5S,6R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-9-pentacyclo[9.7.0.0^{1,3.0^{3,8.0^{12,16]octadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol;2-Hydroxy-1-(5-(1-hydroxy-1-methylethyl)-2-methyltetrahydro-2-furanyl)-3a,6,6,12a-tetramethyl-7-(pentopyranosyloxy)tetradecahydro-1H-cyclopenta[a]cyclopropa[e]phenanthren-5-yl hexopyranoside;NSC650944;SY067110;(2R,3R,4S,5S,6R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-9-pentacyclo[9.7.0.0^{1,3.0^{3,8.0^{12,16]octadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol;16,25-Dihydroxy-3-(pentopyranosyloxy)-20,24-epoxy-9,19-cyclolanostan-6-yl hexopyranoside;MFCD16036240;2-[hydroxy-[5-(1-hydroxy-1-methyl-ethyl)-2-methyl-tetrahydrofuran-2-yl]-tetramethyl-(3,4,5-trihydroxytetrahydropyran-2-yl)oxy-[?]yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol;DTXSID70868831;1ST40060;C17799;(2R,3R,4S,5S,6R)-2-[[(1S,3R,8R,9S,11S,12S,14S,15R,16R)-14-Hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol;HMS3885E12;ASTRAGALOSIDE IV (CONSTITUENT OF ASTRAGALUS) [DSC];ASTRAVERSIANIN XIV;...
CAS No.	84687-43-4
分子式	C₄₁H₆₈O₁₄
分子量	784.97
密度	1.39
沸点	895.7±65.0 °C at 760 mmHg
纯度	98.00%

象形图
警示语
Class
警告声明
UNub
危险声明
Packing Group

搜索质检报告(COA)

搜索SDS

相关产品